NCT02602067
131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer Patients No drug interventions treatment 1 terminated NCT02728921
The Importance of Albumin Infusion Rate for Plasma Volume Expansion Following Major Abdominal Surgery No drug interventions treatment 4 completed NCT04435964
Gender Difference in sidE eFfects of ImmuNotherapy: a Possible Clue to Optimize cancEr tReatment No drug interventions Not Available Not Available completed NCT04519151
Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian Cancer treatment 2 recruiting NCT04235777
Bintrafusp Alfa (M7824) and NHS-IL12 (M9241) Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Metastatic Non-Prostate Genitourinary Malignancies treatment 1 recruiting NCT05030077
Anlotinib Combined With Platinum/Gemcitabine for First Line Treatment of Advanced Urothelial Carcinoma treatment 2 unknown_status NCT05887245
Clinical Significance of Adherent Perinephric Fat in Patients Undergoing Partial Nephrectomy No drug interventions Not Available Not Available recruiting NCT02266745
A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohorts treatment 2 active_not_recruiting NCT01918605
Protection of Rectum From High Radiation Doses Using a Spacer No drug interventions supportive_care Not Available terminated NCT03562897
Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer No drug interventions supportive_care 2 completed NCT04556071
Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancer treatment 2 unknown_status NCT04923178
A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies No drug interventions Not Available Not Available recruiting NCT04831307
68Ga-HTK03149 for Use as a Diagnostic Radiopharmaceutical No drug interventions other Not Available unknown_status NCT03636256
Evaluation of NanoDoce® in Participants With Urothelial Carcinoma treatment 1 / 2 completed NCT02254915
SHTC - EUROPE-1 Synergo Hyperthermia-Chemotherapy by European Urologists' Research Operation Preserving Evolution Study I No drug interventions treatment 3 withdrawn NCT01523652
Pharmacokinetic Study on the Administration of Nadroparin Dosing Serum HGF in Gynecological Patients No drug interventions Not Available Not Available completed NCT03551457
Potential Therapeutic Response In Urogenital Tumors No drug interventions Not Available Not Available completed NCT04462926
Evaluation of Diagnostic Accuracy of [68Ga]Ga-PSMA-11 PET/CT in Primary Staging of Intermediate and High Risk Prostatic Cancer in Men Newly Diagnosed No drug interventions diagnostic Not Available recruiting NCT05592626
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT05288166
A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer) treatment 3 active_not_recruiting NCT06237920
Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab treatment 2 recruiting NCT00377520
A Trial for Patients With Advanced/Recurrent Endometrial Cancer No drug interventions treatment 2 completed NCT06114940
Neoadjuvant Immune-based Combinations in Patients Undergoing Nephrectomy for Locally Advanced ccRCC No drug interventions treatment 2 recruiting NCT04811846
CTC Quantification During TURBT and PKVBT of Transitional Cell Carcinoma in Purging Fluid and Blood No drug interventions treatment Not Available recruiting NCT05413850
Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection No drug interventions treatment 1 / 2 recruiting NCT04922047
Safety and Efficacy Study of Tislelizumab in Combination With BCG in HR-NMIBC Patients (TACBIN-01) No drug interventions treatment 1 / 2 unknown_status NCT04249947
P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC) No drug interventions treatment 1 active_not_recruiting NCT02543645
A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer No drug interventions treatment 1 terminated NCT01217697
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer No drug interventions Not Available Not Available approved_for_marketing NCT04221828
Trial of NanoPac Focal Therapy for Prostate Cancer No drug interventions treatment 2 terminated NCT01422928
Acupuncture for the Immune System in Radiation Cancer Patients No drug interventions treatment 3 withdrawn NCT04060628
Expanded Access to NanoDoce Not Available Not Available available NCT02386111
A Study of Varlilumab (Anti-CD27) and Sunitinib in Patients With Metastatic Clear Cell Renal Cell Carcinoma No drug interventions treatment 1 terminated NCT01408407
Alkagin Paste in the Prevention of Radiation Dermatitis No drug interventions prevention 2 terminated NCT04461509
High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomy No drug interventions other 2 active_not_recruiting NCT00672009
A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate Cancer No drug interventions treatment 2 terminated NCT04644432
Individualized Treatment Strategy for Patients With Metastatic Non-clear Cell Renal Cell Carcinoma No drug interventions treatment 2 unknown_status NCT04566952
Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer No drug interventions treatment 2 unknown_status NCT04679675
Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial No drug interventions health_services_research Not Available completed NCT06353906
Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer No drug interventions treatment 2 recruiting NCT05150236
EVOLUTION: 177Lu-PSMA Therapy Versus 177Lu-PSMA in Combination With Ipilimumab and Nivolumab for Men With mCRPC No drug interventions treatment 2 active_not_recruiting NCT03081858
Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer No drug interventions treatment 1 / 2 completed NCT01316458
Glivec in Prostate Cancer Patients With Rising PSA Following Radical Prostectomy No drug interventions treatment 2 completed NCT00134186
Study of Motexafin Gadolinium for the Treatment of Renal Cell (Kidney) Cancer treatment 2 completed NCT05935748
Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc) No drug interventions treatment 2 recruiting NCT03344757
Health Gatherings - For Your Health After Cancer No drug interventions supportive_care Not Available active_not_recruiting NCT02444195
Guided Imagery in the Perioperative Period in Gynecologic Oncology Patients No drug interventions supportive_care Not Available completed